https://www.selleckchem.com/products/apx2009.html
Lesions were missed mostly due to small metastases or adjacent bladder/urine uptake. [ Ga]Ga-PSMA-11 PET at biochemical recurrence resulted in less than 10% false positive interpretations. Post-radiotherapy prostate uptake was a major source of [ Ga]Ga-PSMA-11 PET false positivity. In few cases, PET correctly detects residual PSMA expression post-radiotherapy, originating however from treated, benign tissue or potentially indolent tumor remnants. ClinicalTrials.gov Identifiers NCT02940262 and NCT03353740. ClinicalTrials.gov Identifiers
Like
Comment
Share
